title: The liver halo sign after tumor ablation.
authors.affiliation: Department of Radiology, Assistance-Publique Hôpitaux de Paris, Hôpital Beaujon, 100 boulevard du Général Leclerc, 92110 Clichy, France; University Paris Diderot, Sorbonne Paris Cité, Paris, France; Centre de Recherche Biomédicale Bichat-Beaujon, Institut National de la Santé et de la Recherche Médicale U1149, Paris, France.
authors.forename: Maxime
authors.initials: M
authors.lastname: Ronot
authors.affiliation: Department of Radiology, Assistance-Publique Hôpitaux de Paris, Hôpital Beaujon, 100 boulevard du Général Leclerc, 92110 Clichy, France.
authors.forename: Damien
authors.initials: D
authors.lastname: Bouda
authors.affiliation: Department of Radiology, Assistance-Publique Hôpitaux de Paris, Hôpital Beaujon, 100 boulevard du Général Leclerc, 92110 Clichy, France; University Paris Diderot, Sorbonne Paris Cité, Paris, France; Centre de Recherche Biomédicale Bichat-Beaujon, Institut National de la Santé et de la Recherche Médicale U1149, Paris, France.
authors.forename: Valérie
authors.initials: V
authors.lastname: Vilgrain
mesh_terms: D000273:Adipose Tissue / Q000000981:diagnostic imaging*; D000368:Aged; D017115:Catheter Ablation; D003951:Diagnostic Errors / Q000517:prevention & control; D006801:Humans; D008113:Liver Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary / Q000601:surgery*; D008297:Male; D061330:Multidetector Computed Tomography; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery*; D011237:Predictive Value of Tests; D012086:Reoperation; D016896:Treatment Outcome